AMPA receptors mediate passive avoidance deficits induced by sleep deprivation

Behavioural Brain Research

Volumn 257, Issue , 2013, Pages 189-196

  Dubiela, Francisco Paulino ^a   Queiroz, Claudio Marcos ^b   Moreira, Karin Di Monteiro ^a   Nobrega, Jose N ^c   Sita, Luciane Valéria ^d   Tufik, Sergio ^a   Hipolide, Debora Cristina ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AMPA receptor; Aniracetam; GYKI 52466; Passive avoidance task; Sleep deprivation

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR; ANIRACETAM; GLUR1; MESSENGER RNA; RECEPTOR SUBTYPE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; HIPPOCAMPUS; IN SITU HYBRIDIZATION; LEARNING; LEARNING DISORDER; MALE; MEMORY; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SLEEP DEPRIVATION; TASK PERFORMANCE; WISTAR RAT;

AMPA RECEPTOR; ANIRACETAM; GYKI-52466; PASSIVE AVOIDANCE TASK; SLEEP DEPRIVATION;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BENZODIAZEPINES; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION; LEARNING DISORDERS; MALE; NOOTROPIC AGENTS; PROTEIN BINDING; PYRROLIDINONES; RATS; RATS, WISTAR; RECEPTORS, AMPA; SLEEP DEPRIVATION; TIME FACTORS; TRITIUM;

EID: 84886406991     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.09.037     Document Type: Article

References (43)

1. Colten H.R., Altevogt B.M. Sleep disorder and sleep deprivation: an unmet public health concern 2006, National Academies Press, Washington, DC.
2. Lim J., Dinges D.F. A meta-analysis of the impact of short-term sleep deprivation on cognitive variables. Psychol Bull 2010, 136:375-389.
3. Bueno O.F., Lobo L.L., Oliveira M.G., Gugliano E.B., Pomarico A.C., Tufik S. Dissociated paradoxical sleep deprivation effects on inhibitory avoidance and conditioned fear. Physiol Behav 1994, 56:775-779.
4. Youngblood B.D., Zhou J., Smagin G.N., Ryan D.H., Harris R.B. Sleep deprivation by the flower pot technique and spatial reference memory. Physiol Behav 1997, 61:249-256.
5. McDermott C.M., LaHoste G.J., Chen C., Musto A., Bazan N.G., Magee J.C. Sleep deprivation causes behavioral, synaptic, and membrane excitability alterations in hippocampal neurons. J Neurosci 2003, 23:9687-9695.
6. 3)H]flunitrazepam binding. Brain Res 2005, 1037:157-163.
7. Dubiela F.P., Oliveira M.G., Moreira K.M., Nobrega J.N., Tufik S., Hipolide D.C. Inverse benzodiazepine agonist beta-CCM does not reverse learning deficit induced by sleep deprivation. Neurosci Lett 2010, 469:169-173.
8. Longordo F., Kopp C., Lüthi A. Consequences of sleep deprivation on neurotransmitter receptor expression and function. Eur J Neurosci 2009, 29:1810-1819.
9. 3H]AMPA receptor binding in the rat hippocampal formation. Neurobiol Learn Mem 1995, 64:257-264.
10. Izquierdo L.A., Barros D.M., Vianna M.R., Coitinho A., de David e Silva T., Choi H., et al. Molecular pharmacological dissection of short- and long-term memory. Cell Mol Neurobiol 2002, 22:269-287.
11. Whitlock J.R., Heynen A.J., Shuler M.G., Bear M.F. Learning induces long-term potentiation in the hippocampus. Science 2006, 313:1093-1097.
12. The ionotropic glutamate receptors 1997, Humana, New Jersey. D.T. Monaghan, R.J. Wenthold (Eds.).
13. Sinha A.K., Mirza A.H., Liu X., Chi O.Z., Weiss H.R. Effect of upregulation of AMPA glutamate receptors on cerebral O(2) consumption and blood flow in rat. Brain Res 1999, 842:230-232.
14. Sinha A.K., Azevedo R., Chi O.Z., Weiss H.R. Down-regulation of AMPA glutamate receptors reduces cerebrocortical metabolic response to stimulation. Neurochem Res 2004, 29:1425-1430.
15. Dos-Anjos S., Martínez-Villayandre B., Montori S., Regueiro-Purriños M.M., Gonzalo-Orden J.M., Fernández-López A. Global ischemia-induced modifications in the expression of AMPA receptors and inflammation in rat brain. Brain Res 2009, 1287:20-27.
16. Bettendorff L., Sallanon-Moulin M., Touret M., Wins P., Margineanu I., Schoffeniels E. Paradoxical sleep deprivation increases the content of glutamate and glutamine in rat cerebral cortex. Sleep 1996, 19:65-71.
17. Mohammed H.S., Aboul Ezz H.S., Khadrawy Y.A., Noor N.A. Neurochemical and electrophysiological changes induced by paradoxical sleep deprivation in rats. Behav Brain Res 2011, 225:39-46.
18. Vyazovskiy V.V., Cirelli C., Pfister-Genskow M., Faraguna U., Tononi G. Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nat Neurosci 2008, 11:200-208.
19. McDermott C.M., Hardy M.N., Bazan N.G., Magee J.C. Sleep deprivation-induced alterations in excitatory synaptic transmission in the CA1 region of the rat hippocampus. J Physiol (London) 2006, 570:553-565.
20. Ravassard P., Pachoud B., Comte J.C., Mejia-Perez C., Scoté-Blachon C., Gay N., et al. Paradoxical (REM) sleep deprivation causes a large and rapidly reversible decrease in long-term potentiation, synaptic transmission, glutamate receptor protein levels, and ERK/MAPK activation in the dorsal hippocampus. Sleep 2009, 32:227-240.
21. Lynch G. Memory and the brain: unexpected chemistries and a new pharmacology. Neurobiol Learn Mem 1998, 70:82-100.
22. Ito I., Tanabe S., Kohda A., Sugiyama H. Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J Physiol (London) 1990, 424:533-543.
23. Jin R., Clark S., Weeks A.M., Dudman J.T., Gouaux E., Partin K.M. Mechanism of positive allosteric modulators acting on AMPA receptors. J Neurosci 2005, 25:9027-9036.
24. Cumin R., Bandle E.F., Gamzu E., Haefely W.E. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents. Psychopharmacology (Berl) 1982, 78:104-111.
25. Bartolini L., Casamenti F., Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav 1996, 53:277-283.
26. Lu Y., Wehner J.M. Enhancement of contextual fear-conditioning by putative (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-d-aspartate (NMDA) receptor antagonists in DBA/2J mice. Brain Res 1997, 768:197-207.
27. Porrino L.J., Daunais J.B., Rogers G.A., Hampson R.E., Deadwyler S.A. Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates. PLoS Biol 2005, 3:e299.
28. Boyle J., Stanley N., James L.M., Wright N., Johnsen S., Arbon E.L., et al. Acute sleep deprivation: the effects of the AMPAKINE compound CX717 on human cognitive performance, alertness and recovery sleep. J Psychopharmacol 2012, 26:1047-1057.
29. Block F., Schwarz M. Correlation between hippocampal neuronal damage and spatial learning deficit due to global ischemia. Pharmacol Biochem Behav 1997, 56:755-761.
30. Gyertyan I., Gigler G., Simo A. The neuroprotective and hypothermic effect of GYKI-52466, a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-antagonist on histological and behavioural variables in the gerbil global ischemia model. Brain Res Bull 1999, 50:179-186.
31. Westerberg E., Monaghan D.T., Cotman C.W., Wieloch T. Excitatory amino acid receptors and ischemic brain damage in the rat. Neurosci Lett 1987, 73:119-124.
32. 3H]Muscimol binding to gamma-aminobutyric acid(A) receptors is upregulated in CA1 neurons of the gerbil hippocampus in the ischemia-tolerant state. Stroke 2002, 33:1698-1705.
33. Suchecki D., Tufik S. Social stability attenuates the stress in the modified multiple platform method for paradoxical sleep deprivation in the rat. Physiol Behav 2000, 68:309-316.
34. Machado R.B., Hipolide D.C., Benedito-Silva A.A., Tufik S. Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery. Brain Res 2004, 1004:45-51.
35. Nobrega J.N., Raymond R., Barlow K., Hamann M., Richter A. Changes in AMPA receptor binding in an animal model of inborn paroxysmal dystonia. Exp Neurol 2002, 176(2):371-376.
36. Gitaí D.L., Martinelli H.N., Valente V., Pereira M.G., Oliveira J.A., Elias C.F., et al. Increased expression of GluR2-flip in the hippocampus of the Wistar audiogenic rat strain after acute and kindled seizures. Hippocampus 2010, 20(1):125-133.
37. Izquierdo I., Medina J.H., Vianna M.R., Izquierdo L.A., Barros D.M. Separate mechanisms for short- and long-term memory. Behav Brain Res 1999, 103:1-11.
38. Ueki A., Miwa C., Miyoshi K. Impairment in the acquisition of passive and active avoidance learning tasks due to bilateral entorhinal cortex lesions. J Neurol Sci 1994, 125:14-21.
39. McGaugh J., Intorini-Collison A., Nagahara A., Cahill L. Involvement of the amygdaloid complex in neuromodulatory influences on memory storage. Neurosci Biobehav Rev 1990, 14:425-431.
40. Hagewoud R., Havekes R., Novati A., Keijser J.N., Van der Zee E.A., Meerlo P. Sleep deprivation impairs spatial working memory and reduces hippocampal AMPA receptor phosphorylation. J Sleep Res 2010, 19:280-288.
41. Boehm J., Kang M.G., Johnson R.C., Esteban J., Huganir R.L., Malinow R. Synaptic incorporation of AMPA receptors during LTP is controlled by a PKC phosphorylation site on GluR1. Neuron 2006, 51:213-225.
42. Nishizaki T., Matsumura T. The aniracetam metabolite 2-pyrrolidinone induces a long-term enhancement in AMPA receptor responses via a CaMKII pathway. Brain Res Mol Brain Res 2002, 98:130-134.
43. Smith A.M., Wehner J.M. Aniracetam improves contextual fear conditioning and increases hippocampal gamma-PKC activation in DBA/2J mice. Hippocampus 2002, 12:76-85.